FARSA-NARS2 Fusion FISH Probe
The FARSA-NARS2 Fusion FISH Probe is used to confirm a fusion of the FARSA and NARS2 genes. The fusion of the FARSA and NARS2 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FARSA-NARS2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FARSA-NARS2-20-AQAQ | 20 (40 μL) | 200 μL |
|
FARSA Gene Summary
Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. This gene encodes a product which is similar to the catalytic subunit of prokaryotic and Saccharomyces cerevisiae phenylalanyl-tRNA synthetases (PheRS). This gene product has been shown to be expressed in a tumor-selective and cell cycle stage- and differentiation-dependent manner, the first member of the tRNA synthetase gene family shown to exhibit this type of regulated expression [provided by RefSeq, Jul 2008]
Gene Name: Phenylalanyl-tRNA Synthetase Alpha Subunit
Chromosome: CHR19: 13033283 -13044558
Locus: 19p13.13
NARS2 Gene Summary
This gene encodes a putative member of the class II family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of asparagine to tRNA molecules. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency 24 (COXPD24). [provided by RefSeq, Mar 2015]
Gene Name: Asparaginyl-tRNA Synthetase 2, Mitochondrial
Chromosome: CHR11: 78147006 -78285909
Locus: 11q14.1
Gene Diseases
The FARSA NARS2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|